← FDA DRUG APPROVALS

FDA NDA · NDA019028

PERIDEX

chlorhexidine gluconate

Sponsor: SOLVENTUM

APPLICATION
NDA019028
TYPE
NDA
ORIGINAL APPROVAL
1986-08-13
LATEST ACTION
2013-04-09
ROUTE
ORAL, DENTAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

PERIDEX · ReferencePrescription
CHLORHEXIDINE GLUCONATE 0.12% · SOLUTION · DENTAL

Approval history

2013-04-09Manufacturing (CMC) · Supplement 21 · priorityAP
2013-01-16Manufacturing (CMC) · Supplement 22 · priorityLabelAP
2013-01-16Labeling · Supplement 20 · standardLabelAP
2010-09-28Manufacturing (CMC) · Supplement 15 · priorityLetterAP
2007-08-08Manufacturing (CMC) · Supplement 14AP
1999-06-07Manufacturing (CMC) · Supplement 11 · priorityAP
1999-06-07Manufacturing (CMC) · Supplement 12 · priorityAP
1997-11-21Manufacturing (CMC) · Supplement 10 · priorityAP
1997-01-08Labeling · Supplement 9 · standardAP
1997-01-08Labeling · Supplement 7 · standardAP
1997-01-08Labeling · Supplement 8 · standardAP
1992-12-04Manufacturing (CMC) · Supplement 6 · priorityAP
1992-08-20Manufacturing (CMC) · Supplement 5 · priorityAP
1991-01-25Manufacturing (CMC) · Supplement 4 · priorityAP
1988-03-31Labeling · Supplement 1AP
1986-08-13Type 3 - New Dosage Form · Original · priorityAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →